Astellas Pharma chief R&D officer Tadaaki Taniguchi at the Astellas Life Sciences Center in Cambridge, Massachusetts. Credit: ...
PET/CT offers excellent accuracy in the staging of high-risk prostate cancer (PCa), yet outcomes-based evidence of the clinical benefit remains limited. We aimed to determine whether the rates of ...
Prostate cancer represents one of the most common malignancies in men in developed countries with increasing incidence in recent years due to the ...
4d
EXCLUSIVE: Inside UK's forgotten Chernobyl 'dirty zone' - toxic sheep, lethal rain and cancer woes
Ahead of the 40th anniversary of Chornobyl, The Mirror visits Bala, Wales, where pollution from the horror blast caused years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results